NIH VideoCast - CTSA Pharmaceutical Assets Portal: Matching Academia and Industry for Drug Repositioning

Skip Navigation

CTSA Pharmaceutical Assets Portal: Matching Academia and Industry for Drug Repositioning

Loading... Loading video...

Air date:	Friday, December 4, 2009, 9:00:00 AM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 112 * This only includes stats from October 2011 and forward.
Category:	Special
Runtime:	01:55:49
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	This meeting will introduce the NIH community to the topic of drug repositioning and learn about the CTSA Pharma Portal. NIH Intramural researchers will be able to learn to match their scientific interests with the repositioning needs of the industry, resulting in an increased number of approved drugs for new indications. Drug repositioning, or finding new uses for drugs originally designed for another purpose, has become more important recently as many pharmaceutical companies are seeing their drug pipelines dry up. With the high cost of drug research and development, drug repositioning offers a way to explore these previously shelved assets. The Clinical and Translational Science Award (CTSA) Pharmaceutical Assets Portal is a tool that aims to match researchers’ scientific knowledge of targets and diseases with the repositioning needs of the pharmaceutical industry to potentially increase the number of approved drugs for alternative uses. Speakers include representatives from Pharma and NIH investigators involved in drug repositioning efforts. http://www.palladianpartners.com/pharm-assets

NLM Title:	CTSA pharmaceutical assets portal : matching academia and industry for drug repositioning / NCRR, NCI, and NIH Clinical Center.
Author:	National Center for Research Resources (U.S.)
Publisher:
Abstract:	(CIT): This meeting will introduce the NIH community to the topic of drug repositioning and learn about the CTSA Pharma Portal. NIH Intramural researchers will be able to learn to match their scientific interests with the repositioning needs of the industry, resulting in an increased number of approved drugs for new indications. Drug repositioning, or finding new uses for drugs originally designed for another purpose, has become more important recently as many pharmaceutical companies are seeing their drug pipelines dry up. With the high cost of drug research and development, drug repositioning offers a way to explore these previously shelved assets. The Clinical and Translational Science Award (CTSA) Pharmaceutical Assets Portal is a tool that aims to match researchers" scientific knowledge of targets and diseases with the repositioning needs of the pharmaceutical industry to potentially increase the number of approved drugs for alternative uses. Speakers include representatives from Pharma and NIH investigators involved in drug repositioning efforts. http://www.palladianpartners.com/pharm-assets.
Subjects:	Drug Discovery--methods Drug Industry--methods Drug Information Services--trends Internet Pharmaceutical Preparations--administration & dosage
Publication Types:	Congress Webcast
NLM Classification:	QV 26.5
NLM ID:	101522181
CIT Live ID:	8215
Permanent link:	https://videocast.nih.gov/watch=8215

Related Videos...